Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Halozyme Therapeutics Inc., 2 years.
Halozyme Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 29, 2026 | Halozyme Therapeutics Inc. | Option exercise | +7,304 | $38.46 | $280,912 |
| Jun 29, 2026 | Halozyme Therapeutics Inc. | Open-market sale | −7,304 | $75.00 | $547,800 |
| May 5, 2026 | Halozyme Therapeutics Inc. | Grant or award | +3,796 | — | — |
| May 1, 2025 | Halozyme Therapeutics Inc. | Grant or award | +4,165 | — | — |
| Apr 25, 2024 | Halozyme Therapeutics Inc. | Grant or award | +6,501 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.